A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer

Stephano S. Mello, Liz J. Valente, Nitin Raj, Jose A. Seoane, Brittany M. Flowers, Jacob McClendon, Kathryn T. Bieging-Rolett, Jonghyeob Lee, Danton Ivanochko, Margaret M. Kozak, Daniel T. Chang, Teri A. Longacre, Albert C. Koong, Cheryl H. Arrowsmith, Seung K. Kim, Hannes Vogel, Laura Delong Wood, Ralph H Hruban, Christina Curtis, Laura D. Attardi

Research output: Contribution to journalArticle

Abstract

The p53 transcription factor is a critical barrier to pancreatic cancer progression. To unravel mechanisms of p53-mediated tumor suppression, which have remained elusive, we analyzed pancreatic cancer development in mice expressing p53 transcriptional activation domain (TAD) mutants. Surprisingly, the p5353,54 TAD2 mutant behaves as a “super-tumor suppressor,” with an enhanced capacity to both suppress pancreatic cancer and transactivate select p53 target genes, including Ptpn14. Ptpn14 encodes a negative regulator of the Yap oncoprotein and is necessary and sufficient for pancreatic cancer suppression, like p53. We show that p53 deficiency promotes Yap signaling and that PTPN14 and TP53 mutations are mutually exclusive in human cancers. These studies uncover a p53-Ptpn14-Yap pathway that is integral to p53-mediated tumor suppression. Mello et al. find that a p53 mutant harboring mutations in the second transcriptional activation domain has enhanced tumor suppression capacities due to hyperactivation of the p53 target gene Ptpn14. Ptpn14 suppresses Yap activity and is required for p53 tumor suppressor activity in pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)460-473.e6
JournalCancer Cell
Volume32
Issue number4
DOIs
StatePublished - Oct 9 2017

Fingerprint

Pancreatic Neoplasms
Neoplasms
p53 Genes
Transcriptional Activation
Mutation
Oncogene Proteins
Transcription Factors

Keywords

  • Hippo pathway
  • mouse model
  • p53
  • pancreas cancer
  • Ptpn14
  • transactivation domain
  • tumor suppressor
  • YAP

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Mello, S. S., Valente, L. J., Raj, N., Seoane, J. A., Flowers, B. M., McClendon, J., ... Attardi, L. D. (2017). A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell, 32(4), 460-473.e6. https://doi.org/10.1016/j.ccell.2017.09.007

A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. / Mello, Stephano S.; Valente, Liz J.; Raj, Nitin; Seoane, Jose A.; Flowers, Brittany M.; McClendon, Jacob; Bieging-Rolett, Kathryn T.; Lee, Jonghyeob; Ivanochko, Danton; Kozak, Margaret M.; Chang, Daniel T.; Longacre, Teri A.; Koong, Albert C.; Arrowsmith, Cheryl H.; Kim, Seung K.; Vogel, Hannes; Wood, Laura Delong; Hruban, Ralph H; Curtis, Christina; Attardi, Laura D.

In: Cancer Cell, Vol. 32, No. 4, 09.10.2017, p. 460-473.e6.

Research output: Contribution to journalArticle

Mello, SS, Valente, LJ, Raj, N, Seoane, JA, Flowers, BM, McClendon, J, Bieging-Rolett, KT, Lee, J, Ivanochko, D, Kozak, MM, Chang, DT, Longacre, TA, Koong, AC, Arrowsmith, CH, Kim, SK, Vogel, H, Wood, LD, Hruban, RH, Curtis, C & Attardi, LD 2017, 'A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer', Cancer Cell, vol. 32, no. 4, pp. 460-473.e6. https://doi.org/10.1016/j.ccell.2017.09.007
Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 2017 Oct 9;32(4):460-473.e6. https://doi.org/10.1016/j.ccell.2017.09.007
Mello, Stephano S. ; Valente, Liz J. ; Raj, Nitin ; Seoane, Jose A. ; Flowers, Brittany M. ; McClendon, Jacob ; Bieging-Rolett, Kathryn T. ; Lee, Jonghyeob ; Ivanochko, Danton ; Kozak, Margaret M. ; Chang, Daniel T. ; Longacre, Teri A. ; Koong, Albert C. ; Arrowsmith, Cheryl H. ; Kim, Seung K. ; Vogel, Hannes ; Wood, Laura Delong ; Hruban, Ralph H ; Curtis, Christina ; Attardi, Laura D. / A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. In: Cancer Cell. 2017 ; Vol. 32, No. 4. pp. 460-473.e6.
@article{3cedc330c7084650ac95e86af988a715,
title = "A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer",
abstract = "The p53 transcription factor is a critical barrier to pancreatic cancer progression. To unravel mechanisms of p53-mediated tumor suppression, which have remained elusive, we analyzed pancreatic cancer development in mice expressing p53 transcriptional activation domain (TAD) mutants. Surprisingly, the p5353,54 TAD2 mutant behaves as a “super-tumor suppressor,” with an enhanced capacity to both suppress pancreatic cancer and transactivate select p53 target genes, including Ptpn14. Ptpn14 encodes a negative regulator of the Yap oncoprotein and is necessary and sufficient for pancreatic cancer suppression, like p53. We show that p53 deficiency promotes Yap signaling and that PTPN14 and TP53 mutations are mutually exclusive in human cancers. These studies uncover a p53-Ptpn14-Yap pathway that is integral to p53-mediated tumor suppression. Mello et al. find that a p53 mutant harboring mutations in the second transcriptional activation domain has enhanced tumor suppression capacities due to hyperactivation of the p53 target gene Ptpn14. Ptpn14 suppresses Yap activity and is required for p53 tumor suppressor activity in pancreatic cancer.",
keywords = "Hippo pathway, mouse model, p53, pancreas cancer, Ptpn14, transactivation domain, tumor suppressor, YAP",
author = "Mello, {Stephano S.} and Valente, {Liz J.} and Nitin Raj and Seoane, {Jose A.} and Flowers, {Brittany M.} and Jacob McClendon and Bieging-Rolett, {Kathryn T.} and Jonghyeob Lee and Danton Ivanochko and Kozak, {Margaret M.} and Chang, {Daniel T.} and Longacre, {Teri A.} and Koong, {Albert C.} and Arrowsmith, {Cheryl H.} and Kim, {Seung K.} and Hannes Vogel and Wood, {Laura Delong} and Hruban, {Ralph H} and Christina Curtis and Attardi, {Laura D.}",
year = "2017",
month = "10",
day = "9",
doi = "10.1016/j.ccell.2017.09.007",
language = "English (US)",
volume = "32",
pages = "460--473.e6",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer

AU - Mello, Stephano S.

AU - Valente, Liz J.

AU - Raj, Nitin

AU - Seoane, Jose A.

AU - Flowers, Brittany M.

AU - McClendon, Jacob

AU - Bieging-Rolett, Kathryn T.

AU - Lee, Jonghyeob

AU - Ivanochko, Danton

AU - Kozak, Margaret M.

AU - Chang, Daniel T.

AU - Longacre, Teri A.

AU - Koong, Albert C.

AU - Arrowsmith, Cheryl H.

AU - Kim, Seung K.

AU - Vogel, Hannes

AU - Wood, Laura Delong

AU - Hruban, Ralph H

AU - Curtis, Christina

AU - Attardi, Laura D.

PY - 2017/10/9

Y1 - 2017/10/9

N2 - The p53 transcription factor is a critical barrier to pancreatic cancer progression. To unravel mechanisms of p53-mediated tumor suppression, which have remained elusive, we analyzed pancreatic cancer development in mice expressing p53 transcriptional activation domain (TAD) mutants. Surprisingly, the p5353,54 TAD2 mutant behaves as a “super-tumor suppressor,” with an enhanced capacity to both suppress pancreatic cancer and transactivate select p53 target genes, including Ptpn14. Ptpn14 encodes a negative regulator of the Yap oncoprotein and is necessary and sufficient for pancreatic cancer suppression, like p53. We show that p53 deficiency promotes Yap signaling and that PTPN14 and TP53 mutations are mutually exclusive in human cancers. These studies uncover a p53-Ptpn14-Yap pathway that is integral to p53-mediated tumor suppression. Mello et al. find that a p53 mutant harboring mutations in the second transcriptional activation domain has enhanced tumor suppression capacities due to hyperactivation of the p53 target gene Ptpn14. Ptpn14 suppresses Yap activity and is required for p53 tumor suppressor activity in pancreatic cancer.

AB - The p53 transcription factor is a critical barrier to pancreatic cancer progression. To unravel mechanisms of p53-mediated tumor suppression, which have remained elusive, we analyzed pancreatic cancer development in mice expressing p53 transcriptional activation domain (TAD) mutants. Surprisingly, the p5353,54 TAD2 mutant behaves as a “super-tumor suppressor,” with an enhanced capacity to both suppress pancreatic cancer and transactivate select p53 target genes, including Ptpn14. Ptpn14 encodes a negative regulator of the Yap oncoprotein and is necessary and sufficient for pancreatic cancer suppression, like p53. We show that p53 deficiency promotes Yap signaling and that PTPN14 and TP53 mutations are mutually exclusive in human cancers. These studies uncover a p53-Ptpn14-Yap pathway that is integral to p53-mediated tumor suppression. Mello et al. find that a p53 mutant harboring mutations in the second transcriptional activation domain has enhanced tumor suppression capacities due to hyperactivation of the p53 target gene Ptpn14. Ptpn14 suppresses Yap activity and is required for p53 tumor suppressor activity in pancreatic cancer.

KW - Hippo pathway

KW - mouse model

KW - p53

KW - pancreas cancer

KW - Ptpn14

KW - transactivation domain

KW - tumor suppressor

KW - YAP

UR - http://www.scopus.com/inward/record.url?scp=85032501232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032501232&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2017.09.007

DO - 10.1016/j.ccell.2017.09.007

M3 - Article

C2 - 29017057

AN - SCOPUS:85032501232

VL - 32

SP - 460-473.e6

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 4

ER -